That strictly could be true, because there may be PR before.
I'm not liking the hype either, but am ok with logic as part of DD.
It is the first time the company has MS as a topic on a scheduled agenda. Is that really to ignore a null outcome with Biogen and pretend nothing happened and publicly go looking for new MS biz Dev opportunities?
No catalyst like actual progress. After talking for 8 plus months - company has not come out with pk/pd data. It is high time they meet their own milestone and issue the data.
At least it will signal that something is happening and trials will start in next 60-90 days